Colistin-resistant Klebsiella pneumoniae: Report of a cluster of 24 cases from a new oncology center in eastern India

Infection Control and Hospital Epidemiology

Volumn 35, Issue 8, 2014, Pages 1076-1077

  Goel, Gaurav ^a   Hmar, Lalawmpuia ^a   Sarkar, Maitrayee ^a   Bhattacharya, Sanjay ^a   Chandy, Mammen ^a  

^a Tata Medical Center ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CHLORAMPHENICOL; COLISTIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; MEROPENEM; MINOCYCLINE; TIGECYCLINE; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIUM ISOLATE; BROTH DILUTION; CLINICAL ARTICLE; DISEASE SURVEILLANCE; EPSILOMETER TEST; FEMALE; HEALTH CENTER; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INDIA; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE INFECTION; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHELOMETRY; NONHUMAN; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TERTIARY CARE CENTER; CANCER CENTER; CROSS INFECTION; DRUG EFFECTS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; COLISTIN; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; HUMANS; INDIA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; ONCOLOGY SERVICE, HOSPITAL;

EID: 84904382725     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/677170     Document Type: Letter

References (10)

1. Bhattacharya S. Early diagnosis of resistant pathogens: how can it improve antimicrobial treatment? Virulence 2013; 4: 172-184.
2. Landman D, Salvani JK, Bratu S, Quale J. Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 2005; 43: 5639-5641.
3. Bhattacharya S, Das D, Bhalchandra R, Goel G. Patient isolation in the high-prevalence setting: challenges with regard to multidrug-resistant gram-negative bacilli. Infect Control Hosp Epidemiol 2013; 34: 650-651.
4. Tóth A, Damjanova I, Puskás E, et al. Emergence of a colistinresistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 2010; 29: 765-769.
5. Kontopoulou K, Protonotariou E, Vasilakos K, et al. Hospital outbreak caused by Klebsiella pneumoniae-producing KPC-2 blactamase resistant to colistin. J Hosp Infect 2010; 76: 70-73.
6. Bogdanovich T, Adams-Haduch JM, Tian GB, et al. Colistinresistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 2011; 53: 373-376.
7. Jernigan MG, Press EG, Nguyen MH, Clancy CJ, Shields RK. The combination of doripenem and colistin is bactericidal and synergistic against colistin-resistant, carbapenemase-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2012; 56: 3395-3398.
8. Tascini C, Tagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin-resistant KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2013; 57: 3990-3993.
9. Hong JH, Clancy CJ, Cheng S, et al. Characterization of porin expression in Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems. Antimicrob Agents Chemother 2013; 57: 2147-2153.
10. Bhattacharya S. Is screening patients for antibiotic-resistant bacteria justified in the Indian context? Indian J Med Microbiol 2011; 29: 213-217.